Adaptimmune Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Adaptimmune Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Adaptimmune Therapeutics | EFFECT: Others
Adaptimmune Therapeutics | 424B3: Prospectus
Adaptimmune Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Adaptimmune Therapeutics | S-4: Registration of securities issued in business combination transactions
Adaptimmune Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Adaptimmune Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Adaptimmune Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Adaptimmune Therapeutics | 424B5: Prospectus
Adaptimmune Therapeutics | EFFECT: Others
Adaptimmune Therapeutics | 424B5: Prospectus
Adaptimmune Therapeutics | 424B5: Prospectus
Adaptimmune Therapeutics | 424B5: Prospectus
Adaptimmune Therapeutics | 424B5: Prospectus
Adaptimmune Therapeutics | EFFECT: Others
Adaptimmune Therapeutics | 424B5: Prospectus
Adaptimmune Therapeutics | 424B5: Prospectus
Adaptimmune Therapeutics | 424B5: Prospectus
Adaptimmune Therapeutics | 424B5: Prospectus
No Data